When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Mitral regurgitation

Última revisión: 13 Sep 2025
Última actualización: 24 Jan 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • dyspnea on exertion
  • decreased exercise tolerance
  • lower extremity edema
  • holosystolic murmur
Todos los datos

Otros factores de diagnóstico

  • fatigue
  • displaced point of maximal impulse
  • orthopnea
  • paroxysmal nocturnal dyspnea
  • palpitations
  • diaphoresis
  • pulmonary closure is louder than aortic closure
  • S3 heart sound
  • diminished S1 heart sound
Todos los datos

Factores de riesgo

  • mitral valve prolapse
  • history of rheumatic heart disease
  • infective endocarditis
  • history of cardiac trauma
  • history of myocardial infarction
  • history of congenital heart disease
  • history of ischemic heart disease
  • left ventricular systolic dysfunction
  • hypertrophic cardiomyopathy
  • anorectic/dopaminergic drugs
  • elevated systolic blood pressure
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • transthoracic echo
  • ECG
Todos los datos

Pruebas diagnósticas que deben considerarse

  • flow convergence method or proximal isovelocity surface area
  • color Doppler flow
  • transesophageal echocardiogram
  • cardiac catheterization
  • cardiac magnetic resonance imaging (CMR)
Todos los datos

Algoritmo de tratamiento

Agudo

acute severe MR

En curso

chronic severe primary MR: asymptomatic

chronic severe primary MR: symptomatic

chronic severe secondary MR

Colaboradores

Autores

Prakash P. Punjabi, FRCS, FESC, MS, MCh, FCCP, FFSTEd, Diplomate NBE

Professor

National Heart and Lung Institute

Imperial College London

Consultant Cardiothoracic Surgeon

Department of Cardiothoracic Surgery

Hammersmith Hospital

Imperial College Healthcare NHS Trust

London

UK

Divulgaciones

PPP is an author of references cited in this topic. PPP declares that he has no competing interests.

Agradecimientos

Dr Prakash P. Punjabi would like to gratefully acknowledge Dr Samir Kapadia and Dr Mehdi H. Shishehbor, previous contributors to this topic.

Divulgaciones

SK and MHS declare that they have no competing interests.

Revisores por pares

Matthew Czarny, MD

Assistant Professor of Medicine

Department of Cardiovascular Medicine

Johns Hopkins University School of Medicine

Baltimore

MD

Divulgaciones

MC is a paid consultant to Medtronic and receives research grants to the institution as a site principal investigator for clinical trials for Medtronic, MedAlliance, and Abbott and a sub-investigator for clinical trials for Edwards Lifesciences. All of these companies manufacture devices used in the transcatheter treatment of structural heart and/or coronary artery disease.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

De Bonis M, Al-Attar N, Antunes M, et al. Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease. Eur Heart J. 2016 Jan 7;37(2):133-9.Texto completo  Resumen

Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e72-227.Texto completo  Resumen

Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632.Texto completo  Resumen

Bonow RO, O'Gara PT, Adams DH, et al. 2020 focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 May 5;75(17):2236-70.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Mitral regurgitation images
  • Diferenciales

    • Acute coronary syndrome (ACS)
    • Infective endocarditis
    • Mitral stenosis
    Más Diferenciales
  • Guidelines

    • 2023 ESC guidelines for the management of infective endocarditis
    • 2021 ESC/EACTS guidelines for the management of valvular heart disease
    Más Guidelines
  • Videos

    Mitral regurgitation (severe)

    Third heart sound gallop

    More videos
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer